Acid zoledronic 4mg/5ml

NAME OF THE MEDICINE

Ozumik

Acid zoledronic 4 mg/5ml Concentrate for solution for infusion

COMPOSITION

Each vial 5 ml contains:

Active ingredient: Zoledronic acid 4 mg

Inactive ingredients: Mannitol, Sodium citrate,  Water for injections.

INDICATIONS

• Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.
• Treatment of adult patients with tumour-induced hypercalcaemia (TIH).

PRESENTATION

Box of 1 vial, 4 vials or 10 vials.

Vial: 5-ml plastic vial made of clear, colourless cycloolefine copolymer with fluoropolymer-coated bromobutyl rubber stopper and aluminium cap with plastic flip-off component

Not all pack sizes may be marketed.

MANUFACTURER

Demo S.A. PHARMACEUTICAL INDUSTRY

21^st km National Road Athens-Lamia,

14568 Krioneri, Athens, Greece.

Read the package insert carefully before use.

For any more information, please consult your doctor

The same group

• Acid Zoledronic 4mg/5ml
• Fluorouracil 250mg/5ml
• Paclitaxel 100mg/16,7ml
• Gemcitabin 1000 mg